01875.HK
BioDlink International Company Limited
HKSE · Healthcare · Biotechnology · CN
HKD 3.80
−0.39%Year over year
Reported trailing growth
- Revenue
- +0.4%
- EBITDA
- -95.4%
- EBIT
- —
- EPS
- —
- Free cash flow
- +102.3%
- Operating cash flow
- -9.2%
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- +19.1%
- EBITDA
- —
- EBIT
- —
- Net income
- —
- EPS
- —
- Free cash flow
- —
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026